 Management outcomes pregnancies human parvovirus infection prospective study large statewide outbreak fifth disease Connecticut pregnant women serologic evidence recent human parvovirus infection patients targeted fetal ultrasonographic examinations signs fetal hydrops pregnant women healthy infants patients miscarriages None fetuses hydrops pregnant women parvovirus evidence IgG IgM antibodies fetal ultrasonography IgM antibodies Percutaneous umbilical blood sampling intrauterine transfusion cases parvovirus-associated hydrops anemia overall fetal loss rate prospective follow-up group